http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016222326-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_adff709a8d25eaa0d3871ff46ff250eb |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-127 |
| filingDate | 2016-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ecf5874b7b757deef6ee5b1e36af957 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ad427faf76bf28e585141b95bccd87d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_368f64f46eb505f828fe8e9e53252d94 |
| publicationDate | 2016-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2016222326-A1 |
| titleOfInvention | Topical formulations having enhanced bioavailability |
| abstract | TOPICAL FORMULATIONS HAVING ENHANCED BIOAVAILABILITY Abstract The present disclosure provides compositions suitable for delivering lipophilic bioactive agents. The compositions may be utilized to treat numerous diseases and conditions that would benefit from the application of a lipophilic bioactive agent. Figure 1: Mean * SD CoQjo Epidermal Concentration vs Dose (Male Pig): (n=6/skin section) 700- Lof Side -q- R1 ide (14)sy DOdng) - 200 Dose (mg) Figure 2: Mean * SD CoQjo Epidermal Concentration vs Dose (Female Pig): (n=6/skin section) - L-t~o SIM (7-Day Odang) 0 1 2 3 4 5 Dose (mg) |
| priorityDate | 2007-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 734.